Federation des caisses Desjardins du Quebec’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio HARP Stock Details HARP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-200	Closed	-$2.27K	–	2491
2023 Q4	$2.27K	Hold	200	–	–	﹤0.01%	2048
2023 Q3	$806	Hold	200	–	–	﹤0.01%	2172
2023 Q2	$1.42K	Hold	200	–	–	﹤0.01%	2105
2023 Q1	$1.49K	Hold	200	–	–	﹤0.01%	2112
2022 Q4	$1.45K	Hold	200	–	–	﹤0.01%	2244
2022 Q3	$1.94K	Hold	200	–	–	﹤0.01%	2267
2022 Q2	$3.82K	Hold	200	–	–	﹤0.01%	2191
2022 Q1	$9.94K	Buy	+200	New	+$10.4K	﹤0.01%	2028

Federation des caisses Desjardins du Quebec's HARP Position: Q1 2024 in Review

Federation des caisses Desjardins du Quebec sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q1 2024, closing a stake of 200 shares — an estimated $2.27K sold.

Federation des caisses Desjardins du Quebec first reported a position in HARP in Q1 2022 and held it in 8 quarters. The position peaked at $9.94K in Q1 2022. 0 funds tracked by Wall St. Rank hold HARP as of Q1 2024.

Federation des caisses Desjardins du Quebec reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 200 Harpoon Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $2.27K.
Federation des caisses Desjardins du Quebec first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q1 2022 and held it in 8 quarters.
Federation des caisses Desjardins du Quebec's Harpoon Therapeutics, Inc. Common Stock position peaked at $9.94K in Q1 2022.
0 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2024, filed 15 May 2024.